Catalog Peptides Market, Global Outlook and Forecast 2024-2031

Report ID: 1651751 | Published Date: Jan 2025 | No. of Page: 127 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story

This report contains market size and forecasts of Catalog Peptides in global, including the following market information:
Global Catalog Peptides Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Catalog Peptides Market Sales, 2017-2022, 2023-2028, (Ton)
Global top five Catalog Peptides companies in 2021 (%)
The global Catalog Peptides market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity: 95% to 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Catalog Peptides include PolyPeptide Group, CSBio, GL Biochem (Shanghai) Ltd., CPC Scientific, Auspep, Peptides International, Inc., Vivitide, Applied Biological Materials (ABM) Inc and Biomatik, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Catalog Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Catalog Peptides Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Catalog Peptides Market Segment Percentages, by Type, 2021 (%)
Purity: 95% to 98%
Purity: Above 98%
Global Catalog Peptides Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Catalog Peptides Market Segment Percentages, by Application, 2021 (%)
Commercial
Academic Research
Others
Global Catalog Peptides Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Catalog Peptides Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Catalog Peptides revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Catalog Peptides revenues share in global market, 2021 (%)
Key companies Catalog Peptides sales in global market, 2017-2022 (Estimated), (Ton)
Key companies Catalog Peptides sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
PolyPeptide Group
CSBio
GL Biochem (Shanghai) Ltd.
CPC Scientific
Auspep
Peptides International, Inc.
Vivitide
Applied Biological Materials (ABM) Inc
Biomatik
Bio-Synthesis Inc
Thermo Fisher Scientific
Genscript Biotech
Bachem
JPT Peptide Technologies
Advanced ChemTech
LifeTein
Eurogentec SA
Elim Biopharm Inc.
Creative Peptides
Abbiotec
NovoPro Bioscience Inc.
KareBay Biochem, Inc.
Ontores Biotechnologies Inc
Severn Biotech
Kaneka Corporation
AnaSpec
AAPPTec
Merck Group

Frequently Asked Questions
Catalog Peptides Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Catalog Peptides Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Catalog Peptides Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports